Security key
00182C103
ANI PHARMACEUTICALS INC - Common Stock (ANIP)
CUSIP: 00182C103
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,278,088
- Total 13F shares
- 21,151,781
- Share change
- +543,995
- Total reported value
- $1,669,958,988
- Put/Call ratio
- 224%
- Price per share
- $78.94
- Number of holders
- 283
- Value change
- +$30,069,338
- Number of buys
- 158
- Number of sells
- 108
Report period
Q4 2025
Institutions
283
Top holders
10
ANIP full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
ANI PHARMACEUTICALS INC SEC filings
ANI PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00182C103
Recent filing periods:
Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
11%
from 13D/G
|
2,548,892
|
$233,478,507 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.7%
|
1,277,470
|
$117,016,252 | — | 30 Sep 2025 | |
| MERIDIAN VENTURE PARTNERS II LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,819,259
|
$102,678,978 | — | 16 Aug 2023 | |
| Meridian Venture Partners II GP, L.P. |
13D/G
|
Robert E. Brown, Jr. |
4.8%
|
1,034,570
|
$66,419,394 | -$9,630,000 | 21 Aug 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
711,708
|
$65,192,453 | — | 30 Sep 2025 | |
| Global Alpha Capital Management Ltd. |
13F
|
Company |
2.8%
|
630,590
|
$57,762,044 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
3.8%
|
818,341
|
$57,136,569 | -$19,037,261 | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
2.6%
|
589,874
|
$54,032,458 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.6%
|
580,085
|
$53,135,786 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.3%
|
505,428
|
$46,297,714 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
458,014
|
$41,959,481 | — | 30 Sep 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
2%
|
450,000
|
$41,220,000 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.8%
|
399,092
|
$36,556,814 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.8%
|
395,075
|
$36,188,870 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.7%
|
379,026
|
$34,718,781 | — | 30 Sep 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.6%
|
360,178
|
$32,992,305 | — | 30 Sep 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
348,680
|
$31,939,088 | — | 30 Sep 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
1.5%
|
343,414
|
$31,456,722 | — | 30 Sep 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.5%
|
340,243
|
$31,166,259 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
317,500
|
$29,083,000 | — | 30 Sep 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.3%
|
291,841
|
$26,732,635 | — | 30 Sep 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.3%
|
291,129
|
$26,667,000 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.3%
|
286,149
|
$26,211,248 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
272,902
|
$24,997,823 | — | 30 Sep 2025 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
1.2%
|
271,345
|
$24,855,202 | — | 30 Sep 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.2%
|
269,678
|
$24,702,504 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.1%
|
252,568
|
$23,135,229 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
235,661
|
$21,586,548 | — | 30 Sep 2025 | |
| Divisadero Street Capital Management, LP |
13F
|
Company |
1.1%
|
234,219
|
$21,454,460 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
232,026
|
$21,253,683 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
1%
|
227,545
|
$20,843,122 | — | 30 Sep 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.97%
|
216,307
|
$19,813,721 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.96%
|
213,006
|
$19,511,350 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.95%
|
210,704
|
$19,302,000 | — | 30 Sep 2025 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.88%
|
195,518
|
$17,909,449 | — | 30 Sep 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.87%
|
194,247
|
$17,793,025 | — | 30 Sep 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.85%
|
190,387
|
$17,439,449 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.85%
|
190,201
|
$17,422,412 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.85%
|
188,599
|
$17,275,668 | — | 30 Sep 2025 | |
| MIZUHO MARKETS AMERICAS LLC |
13F
|
Company |
0.81%
|
180,578
|
$16,540,945 | — | 30 Sep 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.77%
|
172,143
|
$15,768,299 | — | 30 Sep 2025 | |
| APIS CAPITAL ADVISORS, LLC |
13F
|
Company |
0.74%
|
164,000
|
$15,022,400 | — | 30 Sep 2025 | |
| TEACHER RETIREMENT SYSTEM OF TEXAS |
13F
|
Company |
0.69%
|
152,891
|
$14,004,815 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.68%
|
150,658
|
$13,800,273 | — | 30 Sep 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.62%
|
138,900
|
$12,723,240 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.6%
|
134,439
|
$12,314,612 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.59%
|
130,732
|
$11,975,052 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.58%
|
129,096
|
$11,825,194 | — | 30 Sep 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.58%
|
128,689
|
$11,787,912 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.52%
|
116,272
|
$10,650,541 | — | 30 Sep 2025 |
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q4 2025
As of 31 Dec 2025,
ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by
283 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,151,781 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Global Alpha Capital Management Ltd., MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Deep Track Capital, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
283
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
266
Q4 2025 holders
283
Holder diff
17
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.